Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer

Fig. 1

Results of GSVA between recurrent and nonrecurrent PCa patients from five datasets. The activated or suppressed pathways in the TCGA-PRAD (A), MSKCC (B), GSE116918 (C), GSE70768 (D), and GSE70769 (E) cohorts were identified using GSVA, and the Venn diagram (F) showed that E2F_TARGETS was the commonly identified pathway among the GSVA results of the five PCa cohorts

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us